China makes headway on trade secret reform

As China readies to deliberate a draft of its first IP overhaul in over a decade, the government has recently passed two laws and one regulation that could help shield biopharma companies from IP loss.

Mark Cohen, head of the Asia IP project

Read the full 422 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE